Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study-Reference-Cited by-同舟云学术

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study

Published:2015-08-19 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Harmsen Marline G.,Arts-de Jong Marieke,Hoogerbrugge Nicoline,Maas Angela H. E. M.,Prins Judith B.,Bulten Johan,Teerenstra Steven,Adang Eddy M. M.,Piek Jurgen M. J.,van Doorn Helena C,van Beurden Marc,Mourits Marian J. E.,Zweemer Ronald P.,Gaarenstroom Katja N.,Slangen Brigitte F. M.,Vos M. Caroline,van Lonkhuijzen Luc R. C. W.,Massuger Leon F. A. G.,Hermens Rosella P. M. G.,de Hullu Joanne A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-015-1597-y.pdf

Reference67 articles.

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72(5):1117–30.

2. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329–33.

3. Vencken PM, Reitsma W, Kriege M, Mourits MJ, de Bock GH, de Hullu JA, et al. Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands. Ann Oncol. 2013;24(8):2036–42.

4. Russo A, Calo V, Bruno L, Rizzo S, Bazan V, Di Fede G. Hereditary ovarian cancer. Crit Rev Oncol Hematol. 2009;69(1):28–44.

5. Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA. 2012;307(4):382–90.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Ovarian Cancer: Where are We Now and Where are We Going?;Current Oncology Reports;2024-08-08

2. Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy;Gynecologic Oncology;2024-08

3. Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy;Obstetrics & Gynecology Science;2024-07-15

4. Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D;Cancers;2024-03-30

5. Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation;Journal of Gynecology Obstetrics and Human Reproduction;2023-10